/
Cardiovascular
Stroke
187
Pipeline Programs↗
722
Active Trials↗
207
Companies Involved↗
Stroke is a highly competitive landscape with 187 programs across 207 companies. The most active players are Roche, Biogen. 46 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical106
Phase 19
Phase 226
Phase 346
Approved
No programs
Analysis
Modality Breakdown
88%
Small molecule
143 of 162 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 162 classified programs, each share of the total. Modality classified for 96% of 187 pipeline programs.
Analysis
Trial Status
1,721
clinical trials
Completed643 · 37%
Recruiting416 · 24%
Not yet recruiting215 · 12%
Unknown status197 · 11%
Terminated98 · 6%
Active, not recruiting70 · 4%
Other82 · 5%
Clinical Trials
Trial Activity
1721 trials
Functional Improvement in Subacute/Chronic Stroke Patients Through a Non-invasive Virtual-reality Based Telerehabilitation Home System
Recruiting·HHospital Universitari Vall d'Hebron Research Institute·Preclinical·NCT07240948·322 enrolled
Efficacy and Safety of Electroacupuncture Combined With rTMS on Motor Function Recovery After Stroke: A Multi-center Randomized Controlled Clinical Study
Recruiting·—·Preclinical·NCT07113990·180 enrolled
Towards Real-time Personalized Brain State-dependent TMS to Enhance Poststroke Hand Rehabilitation
Recruiting·—·Preclinical·NCT06533176·37 enrolled
Page 1 of 115
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)